Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors-Reference-Cited by-同舟云学术

Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors

Published:2015-08 Issue:15 Volume:23 Page:4364-4374
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Wang Lei,Hou Xuben,Fu Huansheng,Pan Xiaole,Xu Wenfang,Tang Weiping,Fang Hao

Funder

National Natural Science Foundation China

Shandong Natural Science Fund for Distinguished Young Scholars

Program for New Century Excellent Talents in University

Program for Changjiang Scholars and Innovative Research Team in University

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference19 articles.

1. Histone deacetylases and cancer

2. Epigenetics and cancer treatment

3. Recent advances in histone deacetylase targeted cancer therapy

4. HDAC family: What are the cancer relevant targets?

5. Histone deacetylase inhibitors and cancer: from cell biology to the clinic

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and bioactivity evaluations of 8-substituted-quinoline-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitors;Bioorganic & Medicinal Chemistry;2023-05

2. Synthesis of novel 4,7-disubstituted quinoline derivatives as autophagy inducing agents via targeting stabilization of ATG5;Bioorganic Chemistry;2022-10

3. Environmentally Benign Approaches towards the Synthesis of Quinolines;ChemistrySelect;2022-06-09

4. Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents;Bioorganic & Medicinal Chemistry;2022-01

5. Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors;European Journal of Medicinal Chemistry;2022-01